Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1
Leber, Andrew, Hontecillas, Raquel, Zoccoli-Rodriguez, Victoria, Ehrich, Marion, Chauhan, Jyoti, Bassaganya-Riera, JosepLanguage:
english
Journal:
Drug and Chemical Toxicology
DOI:
10.1080/01480545.2019.1679828
Date:
October, 2019
File:
PDF, 1.02 MB
english, 2019